Marrone Bio Innovations I... (MBII)
0.80
-0.20 (-20.00%)
At close: Jan 01, 1970, 12:00 AM
-20.00% (1D)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | 44.37M |
| Net Income (ttm) | -20.89M |
| EPS (ttm) | -0.117 |
| PE Ratio (ttm) | -6.821367521367521 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 7,393,697 |
| Avg. Volume (20D) | 873,211 |
| Open | 1.01 |
| Previous Close | 1.00 |
| Day's Range | 0.75 - 1.02 |
| 52-Week Range | 0.55 - 1.50 |
| Beta | 0.36 |
About MBII
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and ...
Industry Agricultural Inputs
Sector Basic Materials
IPO Date Aug 2, 2013
Employees 153
Stock Exchange NASDAQ
Ticker Symbol MBII
Website https://www.marronebio.com